Autonomix Medical, Inc. Common Stock
AMIX · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | 11.33 | 0.00 |
| FCF Yield | -267.66% | -15.20% | -0.10% | -0.02% |
| EV / EBITDA | 0.55 | -2.37 | -957.21 | 0.00 |
| Quality | ||||
| ROIC | -143.08% | -139.40% | -309.01% | -693.76% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.72 | 0.43 | 0.93 | 0.03 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | -100.00% | -100.00% |
| Free Cash Flow Growth | -24.07% | -259.52% | -378.79% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.83 | 0.50 | 0.43 | 0.00 |
| Interest Coverage | -65.84 | -152.28 | 0.00 | -62.33 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |